CD4 T cells can reject major histocompatibility complex class I-incompatible skin grafts

European Journal of Immunology

Volumn 29, Issue 1, 1999, Pages 156-167

  Wise, Matt ^a   Zelenika, Diana ^a   Bemelman, Frederike ^a   Latinne, Dominique ^b   Bazin, Hervé ^b   Cobbold, Stephen ^a   Waldmann, Herman ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

CD4 T cell; Indirect pathway; Rejection

Indexed keywords

ALLOANTIBODY; CD4 ANTIGEN; CD8 ANTIGEN; COMPLEMENT COMPONENT C3 RECEPTOR; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY TITER; ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; GRAFT REJECTION; IMMUNE DEFICIENCY; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN GRAFT; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY, IMMUNOLOGIC; GRAFT REJECTION; H-2 ANTIGENS; INTERFERON TYPE II; ISOANTIBODIES; LYMPHOCYTE DEPLETION; MICE; MICE, INBRED CBA; MICE, TRANSGENIC; MONOCYTES; SKIN TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032930206     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199901)29:01<156::AID-IMMU156>3.0.CO;2-K     Document Type: Article

References (59)

1. Medawar, P. B., The behaviour and fate of skin autografts and skin homografts in rabbits. J. Anat. 1944. 78: 176-199.
2. Hall, B. M., Cells mediating allograft rejection. Transplantation 1991. 51: 1141-1151.
3. Rosenberg, A. S. and Singer, A., Cellular basis of skin allograft rejection: An in vivo model of immune-mediated tissue destruction. Annu. Rev. Immunol. 1992. 10: 333-358.
4. Sprent, J. and Schaefer, M., Properties of purified T cell subsets I: in vitro responses to class I vs class II H-2 alloantigens. J. Exp. Med. 1985. 162: 2068-2088.
5. b mutant skin allografts differing at class I MHC. Nature 1986. 322: 829-831.
6. Rosenberg, A. S., Mizuochi, T., Sharrow, S. O. and Singer, A., Phenotype, specificity, and function of T cell subsets and T cell interactions involved in skin allograft rejection. J. Exp. Med. 1987. 165: 1296-1315.
7. Wheelahan, J. and McKenzie, I. F. C., The role of T4 and LY-2 cells in skin graft rejection in the mouse. Transplantation 1987. 44: 273-280.
8. Sprent, J., Schaefer, M., Gao, E. K. and Korngold, R. Role of T cell subsets in lethal graft versus host disease directed to class I versus class II differences. I: L3T4 cells can either augment or retard GVHD elicited by Lyt-2 cells in class I different hosts. J. Exp. Med. 1988. 167: 556-569.
9. Rosenberg, A. S., Katz, S. I. and Singer, A., Rejection of skin allografts by CD4 T cells is antigen specific and requires expression of target alloantigen on Ia-epidermal cells. J. Immunol. 1989. 143: 2452-2456.
10. Kitagawa, S., Iwata, H., Sato, S., Shimizu, J., Hamaoka, T. and Fujiwara, H., Heterogenous graft rejection pathways in class I MHC disparate combinations and their differential susceptibility to immunomodulation induced by intravenous presensitization with relevant alloantigens. J. Exp. Med. 1991. 174: 571-581.
11. Sprent, J., Surh, C. D., Agus, D., Hurd, M., Sutton, S. and Heath, W. R., Profound atrophy of the bone marrow reflecting MHC class II restricted destruction of stem cells by CD4 cells. J. Exp. Med. 1994. 180: 307-317.
12. Vallera, D. A., Taylor, P. A., Sprent, J. and Blazar, B. L., The role of host T cell subsets in bone marrow rejection directed to isolated MHC class I vs class II differences of bm1 and bm12 mutant mice. Transplantation 1994. 57: 249-256.
13. Bell, E. B., Rejali, D., Whitby, E. H., Sparshott, S. M. and Yang, C.-P., Allograft rejection in athymic nude rats by transferred T cell subsets. II: The response of naive CD4 and CD8 thoracic duct lymphocytes to an isolated MHC class I disparity. Transplantation 1990. 50: 690-696.
14. Yamamoto, H., Monden, M., Kawai, M., Uenaka, A., Gotoh, M., Mori, T., Sakurai, M., Shiku, H. and Nakayama, E., The role of CD8 and CD4 cells in islet allograft rejection. Transplantation 1990. 50: 120-125.
15. Ichikawa, T., Eiichi, N., Uenaka, A., Monden, M. and Mori, T., Effector cells in allelic H-2 class I incompatible skin graft rejection. J. Exp. Med. 1987. 166: 982-990.
16. Gracie, J. A., Bolton, E. M., Porteous, C. and Bradley, J. A., T cell requirements for the rejection of of renal allografts bearing an isolated class I MHC disparity. J. Exp. Med. 1990. 172: 1547-1557.
17. + T cells are able to reject class I disparate allografts. Transplantation 1997. 64: 335-340.
18. Morton, A. L., Bell, E. B., Bolton, E. M., Marshall, H. E., Roadknight, C., McDonagh, M. and Bradley, J. A., CD4 T cell mediated rejection of MHC class I disparate grafts: a role for alloantibody. Eur. J. Immunol. 1993. 23: 2078-2084.
19. b antigen. J. Exp. Med. 1991. 173: 261-264.
20. Zijlstra, M., Auchincloss, H., Loring, J. M., Chase, C. M., Russell, P. S. and Jaenisch, R., Skin graft rejection by β2 microglobulin deficient mice. J. Exp. Med. 1992. 175: 885-893.
21. + mice are sufficient to mediate the rejection of MHC class II or class I disparate skin grafts. J. Immunol. 1996. 156: 4114-4119.
22. + cells are essential for allorejection. J. Exp. Med. 1996. 184: 2013-2018.
23. Yeoman, H. and Mellor, A. L., Tolerance and MHC restriction in transgenic mice expressing a MHC class I gene in erythroid cells. Int. Immunol. 1992. 4: 59-65.
24. Dalloul, A. H., Ngo, K. and Fung-Leung, W.-P., CD4-negative cytotoxic T cells with a T cell receptor αβ intermediate expression in CD8 deficient mice. Eur. J. Immunol. 1996. 26: 213-218.
25. Bendelac, A., Boitard, C., Bedossa, P., Bazin, H., Bach, J.-F. and Carnaud, C., Adoptive T cell transfer of autoimmune nonobese diabetic mouse diabtes does not require recruitment of host B lymphocytes. J. Immunol. 1988. 141: 2625-2628.
26. Rosenberg, A. S., Finbloom, D. S., Maniero, T. G., Van der Meide, P. H. and Singer, A., Specific prolongation of MHC class II disparate skin allografts by in vivo administration of anti-IFN-γ monoclonal antibody. J. Immunol. 1990. 144: 4648-4650.
27. Dallman, M. J. and Mason, D. W., Induction of Ia antigens on murine epidermal cells during the rejection of skin allografts. Transplantation 1982. 36: 222-224.
28. Finkelman, F. D., Katona, I. M., Mosmann, T. R. and Coffman, R. L., IFN-γ regulates the isotypes of Ig secreted during in vivo humoral immune responses. J. Immunol. 1988. 140: 1022-1027.
29. Cobbold, S. P. and Metcalfe, S., Monoclonal antibodies that define canine homologues of human CD antigens: summary of the first international canine leukocyte antigen workshop (CLAW). Tissue Antigens 1994. 43: 137-154.
30. Ushio, Y., Yamamoto, N., Sanchez-Bueno, A. and Yoshida, R., Failure to reject an allografted tumour after elimination of macrophages in mice. Microbiol. Immunol. 1996. 40: 489-498.
31. Huitinga, I., van Rooijen, N., de Groot, C. J., Uitdehaag, B. M. and Dijkstra, C. D., Suppression of EAE in Lewis rats after elimination of macrophages. J. Exp. Med. 1990. 172: 1025-1033.
32. Rosen, H. and Gordon, S., Monoclonal antibody to the murine type 3 complement receptor inhibits adhesion of myelomonocytic cells in vitro and inflammatory cell recruitment in vivo. J. Exp. Med. 1987. 166: 1685-1701.
33. Mohler, K. M., Torrance, D. S., Smith, C. A., Goodwin, R. G., Stremler, K. E., Fung, V. P., Madani, H. and Widmer, M. B., Soluble tumor necrosis factor receptors are effective therapeutic agents in lethal endotoxaemia and function simultaneously as both TNF carriers and TNF antagonists. J. Immunol. 1993. 151: 1548-1561.
34. Mintz, B. and Silvers, W. K., 'Intrinsic' immunological tolerance in allophenic mice. Science 1967. 158: 1484-1487.
35. Mintz, B. and Silvers, W. K., Histocompatibility antigens on melanoblasts and hair follicle cells. Transplantation 1970. 9: 497-505.
36. Bishop, D. K., Chan, S., Li, W., Ensley, R. D., Xu, S. and Eichwald, E. J., CD4-positive helper T lymphocytes mediate mouse cardiac allograft rejection independent of donor alloantigen specific cytotoxic T lymphocytes. Transplantation 1993. 56: 892-897.
37. + T cells results in Th2 cytokine production and alternative mechanisms of allograft rejection. Transplantation 1995. 59: 1155-1161.
38. + T cell populations. Transplantation 1996. 62: 300-302.
39. Doody, D. P., Stenger, K. S. and Winn, H. J., Immunologically nonspecific mechanisms of tissue destruction in the rejection of skin grafts. J. Exp. Med. 1994. 179: 1645-1652.
40. Frelinger, J. G., Hood, L., Hill, S. and Frelinger, J. A., Mouse epidermal Ia molecules have a bone marrow origin. Nature 1979. 282: 321-323.
41. Rosenberg, A. S., Munitz, T. I., Maniero, T. G. and Singer, A., Cellular basis of skin allograft rejection across a class I MHC barrier in mice depleted of CD8 T cells in vivo. J. Exp. Med. 1991. 173: 1463-1471.
42. McCarthy, S. A., Kaldjian, E. and Singer, A., Induction of anti-CD8 resistant cytotoxic T lymphocytes by anti-CD8 antibodies. J. Immunol. 1988. 141: 3737-3746.
43. Qin, S., Transplantation tolerance with monoclonal antibodies. PhD thesis Cambridge University, Cambridge 1989.
44. Golding, H. and Singer, A., Role of accessory cell processing and presentation of shed H-2 alloantigens in allospecific cytotoxic T lymphocyte responses. J. Immunol. 1984. 133: 597-605.
45. Fangmann, J., Dalchau, R. and Fabre, J. W., Rejection of skin allografts by indirect allorecognition of donor class I MHC peptides. J. Exp. Med. 1992. 175: 1521-1529.
46. Nairn, R., Yamaga, K. and Nathenson, S. G., Biochemistry of the gene products from murine MHC mutants. Annu. Rev. Genet. 1980. 14: 241-277.
47. bm3. J. Immunol. 1989. 143: 1674-1679.
48. Pease, L. R., Horton, R. M., Pullen, J. K., Hunt, H. D., Yun, T. J., Rohren, E. M., Jobe, S. M. and Allen, K. S., Amino acid changes in the peptide binding site have structural consequences at the surface of class I glycoproteins. J. Immunol. 1993. 150: 3375-3381.
49. + cytotoxic T cells can lyse targets via class I molecules and can be blocked by monoclonal antibody against T4 molecules. J. Immunol. 1984. 133: 1705-1709.
50. Yang, Y. and Wilson, J. M., Clearance of adenovirus-infected hepatocytes by MHC class I restricted CD4 CTLs in vivo. J. Immunol. 1995. 155: 2564-2570.
51. Yoshida, R., Takikawa, O., Oku, T. and Habara-Ohkubo, A., Mononuclear phagocytes: A major population of effector cells responsible for rejection of allografted tumor cells in mice. Proc. Natl. Acad. Sci. USA 1991. 88: 1526-1530.
52. +-dependent, Fas and perforin-independent apoptotic death of allografted tumour cells by a type of activated macrophage. J. Immunol. 1997. 159: 15-21.
53. Larsen, C. P., Alexander, D. Z., Hendrix, R., Ritchie, S. C. and Pearson, T. C., Analysis of effector mechanisms in murine cardiac allograft rejection. Transplantation. 1995. 60: 221-224.
54. Larsen, C. P., Steinman, R. M., Witmer-Pack, M., Hankins, D. F., Morris, P. J. and Austyn, J. M., Migration and maturation of Langerhans cells in skin transplants and explants. J. Exp. Med. 1990. 172: 1483-1489.
55. Davies, J. D., Leong, L. Y. W., Mellor, A. L., Cobbold, S. P. and Waldmann, H., T cell suppression in transplantation tolerance through linked recognition. J. Immunol. 1996. 156: 3602-3607.
56. Cobbold, S. P., Jayasuriya, A., Nash, A., Prospero, T. D. and Waldmann, H., Therapy with Monoclonal antibodies by elimination of T-cell subsets in vivo. Nature 1984. 312: 548-551.
57. Qin, S., Cobbold, S. P., Tighe, H., Benjamin, R. J. and Waldmann, H., CD4 Monoclonal antibody pairs for immunosuppression and tolerance induction. Eur. J. Immunol. 1987. 17: 1159-1165.
58. Leong, L. Y., Qin, S., Cobbold, S. P. and Waldmann, H., Classical transplantation tolerance in the adult: the interaction between myeloablation and immunosuppression. Eur. J. Immunol. 1992. 22: 2825-2830.
59. Hale, G., Dyer, M. J., Clark, M. R., Phillips, J. M., Marcus, R., Riechmann, L., Winter, G. and Waldmann, H., Remission induction in non-Hodgkin lymphoma with reshaped monoclonal antibody CAMPATH-1H. Lancet 1988. ii: 1394-1399.